Medicinal chemistry articles within British Journal of Cancer

Featured

• Article | 26 August 2021

  CCT245718, a dual FLT3/Aurora A inhibitor overcomes D835Y-mediated resistance to FLT3 inhibitors in acute myeloid leukaemia cells

  • Muhammad Usama Tariq
  • , Muhammad Furqan
  •  & Amir Faisal

• Review Article
  04 November 2020 | Open Access

  Insights into the role of sialylation in cancer progression and metastasis

  • Christopher Dobie
  •  & Danielle Skropeta

• Comment
  26 June 2020 | Open Access

  How promising is phototherapy for cancer?

  • Huayun Shi
  •  & Peter J. Sadler

• Article
  11 February 2019 | Open Access

  Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs

  • Giulia Dell’Omo
  • , Daniela Crescenti
  •  & Paolo Ciana

• Molecular Diagnostics
  22 November 2016 | Open Access

  Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study

  • Sanne Samuels
  • , Balazs Balint
  •  & Susy Scholl

• Mini Review
  12 April 2016 | Open Access

  Hypoxia-activated prodrugs: paths forward in the era of personalised medicine

  • Francis W Hunter
  • , Bradly G Wouters
  •  & William R Wilson

• Translational Therapeutics
  05 August 2014 | Open Access

  Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells

  • C D’Amato
  • , R Rosa
  •  & R Bianco

• Letter to the Editor
  08 June 2010 | Open Access

  Regarding: ‘Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array’

  • J Pander
  • , H Gelderblom
  •  & H-J Guchelaar

• Clinical Study
  18 May 2010 | Open Access

  Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies

  • P Hamberg
  • , N Steeghs
  •  & S Sleijfer

• Clinical Study
  30 March 2010 | Open Access

  Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

  • N Penel
  • , S Clisant
  •  & A Adenis

• Translational Therapeutics
  16 March 2010 | Open Access

  Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration

  • G Sonvilla
  • , S Allerstorfer
  •  & B Marian

• Book Review
  16 February 2010 | Open Access

  Cancer Drug Discovery and Development: Stem Cells and Cancer

  • M H Stewart

• Translational Therapeutics
  09 February 2010 | Open Access

  The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate

  • S T Russell
  • , P M A Siren
  •  & M J Tisdale